Literature DB >> 21503752

Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep.

Ali Asghar Mozaffari1, Amin Derakhshanfar.   

Abstract

PURPOSE: The purpose of this study was to evaluate the brain, renal, and hepatic effects of three NSAIDs (flunixin meglumine, ketoprofen, and phenylbutazone) when administered IV to clinically normal Iranian fat-tailed sheep.
METHODS: The experiments were conducted on twenty clinically normal adult female sheep. Sheep were randomly assigned to four groups: saline (n = 5), flunixin meglumine (n = 5), ketoprofen (n = 5), and phenylbutazone (n = 5). Drug administration was initiated at 8 AM: on day 1 and continued every 12 h for 12 days. Flunixin meglumine, ketoprofen, and phenylbutazone were administered at dose rate of 2.2, 4, and 4 mg/kg, respectively. Daily blood and urine samples were collected from all sheep for hematologic, enzymes activity, and urinalysis. Immediately after euthanasia, complete necropsy was performed on all sheep and gross lesions were recorded.
RESULTS: Clinical, hematological, serum, and urine analysis and histopatholgical findings were described.
CONCLUSION: When the use of these compounds is contemplated in clinical cases, the risk of adverse effects and the comparative toxic potential should be considered, along with the efficacy of the compound for the condition being treated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503752     DOI: 10.1007/s11250-011-9866-5

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  18 in total

1.  Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.

Authors:  J N Moore; M M Hardee; G E Hardee
Journal:  Am J Vet Res       Date:  1986-01       Impact factor: 1.156

2.  Physiological, biochemical and haematological effects on horses of a phenylbutazone paste.

Authors:  P Lees; A J Higgins
Journal:  Vet Rec       Date:  1987-07-18       Impact factor: 2.695

3.  Renal papillary necrosis in horses.

Authors:  D E Gunson
Journal:  J Am Vet Med Assoc       Date:  1983-02-01       Impact factor: 1.936

4.  The effects of phenylbutazone on the intestinal mucosa of the horse: a morphological, ultrastructural and biochemical study.

Authors:  C L Meschter; M Gilbert; L Krook; G Maylin; R Corradino
Journal:  Equine Vet J       Date:  1990-07       Impact factor: 2.888

Review 5.  Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.

Authors:  A V Manoukian; J L Carson
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

6.  Effects of flunixin meglumine on blood pressure and fluid compartment volume changes in ponies given endotoxin.

Authors:  N J Dunkle; G D Bottoms; J F Fessler; K Knox; O F Roesel
Journal:  Am J Vet Res       Date:  1985-07       Impact factor: 1.156

7.  Renal medullary crest necrosis associated with phenylbutazone therapy in horses.

Authors:  W K Read
Journal:  Vet Pathol       Date:  1983-11       Impact factor: 2.221

Review 8.  Phenylbutazone in the horse: a review.

Authors:  T Tobin; S Chay; S Kamerling; W E Woods; T J Weckman; J W Blake; P Lees
Journal:  J Vet Pharmacol Ther       Date:  1986-03       Impact factor: 1.786

9.  Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies.

Authors:  G E Burrows
Journal:  Am J Vet Res       Date:  1981-01       Impact factor: 1.156

10.  Phenylbutazone toxicity in ponies.

Authors:  D H Snow; J A Bogan; T A Douglas; H Thompson
Journal:  Vet Rec       Date:  1979-07-14       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.